期刊文献+

曼月乐治疗子宫内膜异位性疾病的临床观察 被引量:5

暂未订购
导出
摘要 目的观察左旋-18甲基炔诺酮宫内缓释系统(LNG-IUS)治疗子宫内膜异位性疾病的临床效果。方法回顾性分析2009年2月~2010年8月本院门诊子宫内膜异位性疾病患者的临床资料,均于月经来潮第3~5天宫腔放置LNG-IUS,比较放置前后痛经程度、月经变化等。结果 28例子宫内膜异位性疾病患者在带器期间痛经缓解率100%,月经量明显减少,其他部位内异病灶症状好转。结论子宫内膜异位性疾病放入LNG-IUS对无生育要求的妇女安全、有效,值得临床推广。
作者 邱淑芬 王芸
出处 《中国现代医生》 2011年第14期121-121,123,共2页 China Modern Doctor
基金 2010年浙江省衢州市科技项目 项目编号:20101080
  • 相关文献

参考文献7

二级参考文献40

  • 1高雨农,蒋国庆.释放左旋18甲基炔诺酮宫内节育器对三苯氧胺引起子宫内膜病变的治疗[J].中国妇产科临床杂志,2004,5(5):359-362. 被引量:10
  • 2蒋国庆,廉玉茹.释放左炔诺孕酮的宫内节育器治疗子宫腺肌病[J].中国妇产科临床杂志,2005,6(3):177-178. 被引量:51
  • 3杨幼林,郑淑蓉,李克敏,张炳兰.两种不同剂量米非司酮治疗子宫肌瘤的疗效观察[J].中华妇产科杂志,1996,31(10):624-626. 被引量:217
  • 4Rutanen EM. Endometrial response to intrauterine release of levonorgestrel. Gynecol Forum, 1998, 3(1): 11-14.
  • 5Luukkainen T, Pakarinen P, Toivonen J. Progestin-releasing intrauterine system. Semi Reprod Med, 2001, 19(4): 355-363.
  • 6Zalel Y, Shulman A, Lidor A, et al. The local progestational efffect of the levonorgestrel-releasing intrauterine system: a sonographic and Doppler flow study. Hum Reprod, 2002, 17(11):2878-2880.
  • 7Guillebaud .I. The levnorgestrel intrauterine systemL: a clinical perspective from the UK. Ann N Y Acad Sci, 2003, 997(2): 185-193.
  • 8Backman T, Huhtala S, Luoto R, et al. Advance information improves improves user satisfaction with the levonorgestrel intrauterine system.Obstet Gynecol, 2002, 99(4): 608-613.
  • 9French R, Cowan F, Mansour D, et al. Hormonally impregnated intrauterine systems(IUSs) versus other forms of reversible contraceptives as effective methods of preventing pregnancy. Cochrane Database Syst Rev, 2001,(2):CD001776.
  • 10Backman T, Rauramo I, Huhtala S, et al. Pregancy during the use of levonorgestrel intrauterine system. Am J Obstet Gynecol, 2004, 190(1):50-54.

共引文献493

同被引文献56

  • 1熊玉华.子宫内膜异位症的临床治疗分析[J].求医问药(下半月刊),2012,10(12). 被引量:3
  • 2聂莉,谢梅青,王良岸.左炔诺孕酮宫内缓释系统对增生过长子宫内膜IGF-I和IGF-II及其相应受体表达的影响[J].实用诊断与治疗杂志,2006,20(8):550-552. 被引量:5
  • 3邓姗,郎景和,冷金花,刘珠凤,孙大为,朱兰.曼月乐对子宫内膜异位症患者在位内膜增殖与凋亡的影响[J].生殖与避孕,2006,26(10):589-592. 被引量:114
  • 4Reslova T,Tosner J,Resl M,et al. Endometrial polyps a clinical study of 245 cases[J]. Arch Gynecol Obstet, 1999, 262('3-4) : 133-139.
  • 5Inceboz US,Nese N,Uyar Y,et al. Hormone receptor ex- pressions and proliferation markers in postmenopausal en- dometrial polyps[J]. Gynecol Obstet Invest, 2006,61 ( 1 ) : 24-28.
  • 6Stygar D,Muravitskaya N,Eriksson B,et al. Efects of SERM (selective estrogen receptor modniator) treatment on growth and proliferation in the rat uterine [J].Reprod Biol Endocdno 1,2003,1 ( 1 ) : 40-48.
  • 7Robboy SJ,Anderson MC, Russel P. Pathology of the fe- male reproductive tract[M]. London:Churchill Livingstone, 2002: 285-303.
  • 8Reslova T,Tosner J, Resl M,et al. Endometrial polyps a clinical study of 245 cases[J]. Arch Gyneeol Obstet, 1999, 262(3-4) : 133-139.
  • 9Gome K,Rosae-Silva JC,Garcia SB,et al. Effects of the levonorgestrel-releasing intrauterine system on cell prolif- eration, Fas expression and steroid receptors in endomteio sis lesions and normal endometrium[J]. Hum Reprod, 2008, 24(11):2736-2745.
  • 10Gul A,Ugur M,Iskender C,et al. Immunohistoehemical expression of estrogen and progesterone resceptors in en dometrial polyps and its relationship to clinical parameters Arch Gynecol Obster, 2010,281 (3) : 479-483.

引证文献5

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部